Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1337 of 6351
-
Laser light could ease knee arthritis without drugs or surgery
Symptom relief Not yet recruitingThis randomized placebo-controlled trial aims to evaluate the effectiveness of High-Intensity Laser Therapy (HILT) as an adjunct to standard outpatient physiotherapy in patients with knee osteoarthritis. Seventy-two participants will be randomly assigned to receive either convent…
Sponsor: University of Rzeszow • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New hope for advanced cancer patients as experimental drug enters trials
Disease control Recruiting nowTo evaluate the safety, tolerability, efficacy and pharmacokinetic characteristics of ICP-B208 in the trial participants of unresectable advanced or metastatic solid tumors
Phase 1/2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a common numbing drug cut opioid needs in sickle cell emergencies?
Symptom relief Recruiting nowThe purpose of the study is to determine whether adding lidocaine to standard of care in pain management during severe vaso-occlusive crisis has an effect on the cumulative opioid consumption expressed as morphine milligram equivalent.
Phase 3 • Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 10, 2026 08:00 UTC
-
Could a repurposed drug boost brain recovery after severe injury?
Disease control By invitation onlyThe purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recovery will be measured throughout the study. The study drug listed below is approved by the U.S. Food and Drug Administrati…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study is open to adults with ST elevation myocardial infarction (heart attack) undergoing primary percutaneous coronary intervention (PCI). The purpose of this study is to determine whether a medicine called Xolatryp is safe and effective in improving cardiac outcomes. One d…
Phase 2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for kidney stone sufferers: drug and diet combo tested in major trial
Disease control Recruiting nowThe aim of this randomized trial with a 2-by-2 factorial design is to test the efficacy of the SGLT2 inhibitor empagliflozin and personalized dietary counseling based on 24-hr urine collection results and dietary assessments for kidney stone recurrence prevention in patients with…
Phase 3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New Non-Addictive pain drug could curb opioid dependence after surgery
Disease control Recruiting nowThe purpose of the study is to investigate the efficacy of suzetrigine for treatment of acute postoperative pain among surgical patients identified as high risk for persistent postoperative opioid use (POU). Using a validated artificial intelligence predictive model (termed SurgN…
Phase 4 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Virtual streets could shape Kids' vision and feelings
Knowledge-focused Recruiting nowThe primary objective is to determine how streetscape exposure influences children's visual perception and psychological perception. The secondary aim is to identify streetscape elements associated with both visual and psychological perception, thereby providing evidence for envi…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
AI takes on knee scans: a smarter way to spot joint problems?
Knowledge-focused CompletedThis retrospective observational study aims to investigate imaging features of the knee joint on magnetic resonance imaging (MRI) using artificial intelligence (AI)-based image analysis. Existing knee MRI examinations from eligible participants are retrospectively reviewed and an…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Could a saffron-derived compound boost radiation for sarcoma?
Disease control Not yet recruitingThis is phase II randomized, multicenter study of treatment with L-TC and preoperative HFRT in patients who were aged 18 years or older with documented localised or locally advanced soft-tissue sarcoma of the extremity. Eligible patients will be randomly assigned 2:1 to receive …
Phase 2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug aims to stop IgG4 disease relapses without Long-Term steroids
Disease control Not yet recruitingThe goal of this clinical trial is to learn if IMM0306 works to reduce the risk of disease relapse in participants with IgG4-related disease (IgG4-RD). It will also learn about the safety and tolerability of IMM0306. The main questions it aims to answer are: * Does IMM0306 reduc…
Phase 2/3 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Zap your brain to sharper thinking? new trial tests TIS for memory loss
Symptom relief Recruiting nowThis study aims to evaluate the efficacy and safety of temporal interference stimulation (TIS), a non-invasive neuromodulation technique, in improving cognitive function in patients with cognitive impairment. TIS uses two high-frequency currents applied transcranially, which inte…
Sponsor: Tianjin Huanhu Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Blood tests and a new score may forecast brain bleed recovery
Knowledge-focused By invitation onlyCurrently, we lack sufficiently reliable tools to accurately predict, in the first few hours, the vital prognosis, functional status, and quality of life of patients with intracerebral hemorrhage (ICH). With new neurosurgical techniques and improvements in neurocritical care, it …
Sponsor: Germans Trias i Pujol Hospital • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New stroke treatment aims to bust clots directly in the brain
Disease control Not yet recruitingStudy purpose: A multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) phase III trial is planned to evaluate the efficacy and safety of intra-arterial thrombolysis (IAT) in patients with acute ischemic stroke caused by medium vessel occlusion (MeVO), compar…
Phase 3 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Scientists track hidden threat of antibiotic resistance in lung patients
Knowledge-focused Not yet recruitingAntimicrobial resistance (AMR) refers to the ability of microorganisms like bacteria, viruses, fungi and parasites to resist the effects of antimicrobial drugs (such as antibiotics) which are widely used as treatment. AMR poses an escalating global health threat, contributing to …
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can a diuretic shield kidneys from contrast dye in heart failure?
Disease control Recruiting nowThe K-PROSE study is a randomized clinical investigation evaluating strategies to prevent contrast-induced acute kidney injury (CI-AKI) in patients hospitalized with acute heart failure and moderate renal dysfunction (eGFR 30-75 mL/min/1.73 m²). Patients requiring contrast-enhanc…
Sponsor: Jin Joo Park • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Electric implant aims to ease Amputees' lingering pain
Symptom relief Not yet recruitingThis is a single-center, prospective, within-subject study. This study seeks to enroll a total of 32 prospective subjects who will undergo surgical implantation of the FDA-approved Altius® system. Subjects will be followed longitudinally and will complete a series of patient-repo…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Smart sensors aim to outsmart sepsis in ICU patients
Knowledge-focused Not yet recruitingThe purpose of this clinical investigation is to evaluate the integration of data from the CPC12S telemonitoring device, the CPC temperature/humidity sensor, and the IDRO sweat lactate sensor into a single system for the prediction of sepsis onset in ICU patients at risk of devel…
Sponsor: Check Point R & D Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Could a cystic fibrosis drug boost brain blood flow in heart failure?
Disease control Recruiting nowCognitive impairment (CI) is highly prevalent in patients with heart failure with reduced ejection fraction (HFrEF), which has significant implications for disease management, quality of life and clinical outcomes. Currently, there are no specific treatments for CI aside from the…
Phase 2 • Sponsor: Qanatpharma AG • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Poop pills could help kids with colitis stay healthy
Disease control Not yet recruitingThe purpose of this study is to evaluate whether FMT by frozen stool capsules in pediatric UC patients in remission after corticosteroid treatment, can modify their dysbiotic gut microbiota by increasing the richness of their microbiota at 6 months.
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC